Cargando…
State of the Art Review of Cell Therapy in the Treatment of Lung Disease, and the Potential for Aerosol Delivery
Respiratory and pulmonary diseases are among the leading causes of death globally. Despite tremendous advancements, there are no effective pharmacological therapies capable of curing diseases such as COPD (chronic obstructive pulmonary disease), ARDS (acute respiratory distress syndrome), and COVID-...
Autores principales: | Brave, Hosanna, MacLoughlin, Ronan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7503246/ https://www.ncbi.nlm.nih.gov/pubmed/32899381 http://dx.doi.org/10.3390/ijms21176435 |
Ejemplares similares
-
Defining a Regulatory Strategy for ATMP/Aerosol Delivery Device Combinations in the Treatment of Respiratory Disease
por: Woods, Niamh, et al.
Publicado: (2020) -
A narrative review on trans-nasal pulmonary aerosol delivery
por: Li, Jie, et al.
Publicado: (2020) -
Comparison of aerosol delivery across combinations of drug delivery interfaces with and without concurrent high-flow nasal therapy
por: Bennett, Gavin, et al.
Publicado: (2019) -
In Vitro Study of the Effect of Breathing Pattern on Aerosol Delivery During High-Flow Nasal Therapy
por: Bennett, Gavin, et al.
Publicado: (2019) -
Aerosol release, distribution, and prevention during aerosol therapy: a simulated model for infection control
por: Mac Giolla Eain, Marc, et al.
Publicado: (2021)